Days Post Vaccination (DPV) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Treatment | Assay | 0 | 11 | 18 | 24 | 31 | 38 | 43 | 48 |
LE/C | wv-ELISAA | 0 (0/10)1 | 30 (3/10)b | 100 (10/10)* | 100 (10/10)* | 100 (10/10) | 100 (10/10)* | 100 (10/10) | 100 (10/10)* |
IFAB | 0 (0/10) | 10 (1/10)b | 70 (7/10)* | 60 (6/10)* | 100 (10/10) | 50 (5/10)* | 60 (6/10) | 100 (10/10)* | |
SVNC | 0 (0/10) | 100 (10/10)a | 100 (10/10)* | 100 (10/10)* | 100 (10/10) | 90 (9/10)* | 90 (9/10) | 70 (7/10)* | |
NV/C | wv-ELISAA | 0 (0/10) | 0 (0/10) | 0 (0/10) | 0 (0/10) | 0 (0/10) | 10 (1/10) | 0 (0/10) | 0 (0/10) |
IFAB | 0 (0/10) | 0 (0/10) | 0 (0/10) | 0 (0/10) | 0 (0/10) | 0 (0/10) | 0 (0/10) | 0 (0/10) | |
SVNC | 0 (0/10) | 0 (0/10) | 0 (0/10) | 0 (0/10) | 0 (0/10) | 0 (0/10) | 0 (0/10) | 0 (0/10) | |
NV/NC | wv-ELISAA | 0 (0/10) | 20 (2/10) | 0 (0/10) | 0 (0/10) | 0 (0/10) | 0 (0/10) | 0 (0/10) | 0 (0/10) |
IFAB | 0 (0/10) | 0 (0/10) | 0 (0/10) | 0 (0/10) | 0 (0/10) | 0 (0/10) | 0 (0/10) | 0 (0/10) | |
SVNC | 0 (0/10) | 0 (0/10) | 0 (0/10) | 0 (0/10) | 0 (0/10) | 0 (0/10) | 0 (0/10) | 0 (0/10) | |
RP/C | wv-ELISAA | 0 (0/10) | 0 (0/10)* | 20 (2/10)ab | 20 (2/10)* | 100 (10/10) | 100 (10/10) | 100 (10/10) | 100 (10/10) |
IFAB | 0 (0/10) | 0 (0/10)* | 0 (0/10)b | 10 (1/10)* | 100 (10/10) | 100 (10/10) | 100 (10/10) | 100 (10/10) | |
SVNC | 0 (0/10) | 50 (5/10)* | 80 (8/10)a | 50 (5/10)* | 100 (10/10) | 100 (9/9) | 100 (10/10) | 100 (10/10) | |
RPAdj/C | wv-ELISAA | 0 (0/10) | 0 (0/10)* | 70 (7/10)* | 60 (6/10)* | 100 (10/10) | 100 (10/10) | 100 (10/10) | 100 (10/10) |
IFAB | 0 (0/10) | 0 (0/10)* | 50 (5/10)* | 100 (10/10)* | 100 (10/10) | 100 (10/10) | 100 (10/10) | 100 (10/10) | |
SVNC | 0 (0/10) | 60 (6/10)* | 100 (10/10)* | 100 (10/10)* | 100 (10/10) | 100 (10/10) | 100 (10/10) | 100 (10/10) |